CellaVision AB (publ) (STO:CEVI)
150.60
+0.80 (0.53%)
Apr 14, 2026, 5:29 PM CET
CellaVision AB Revenue
In the year 2025, CellaVision AB had annual revenue of 758.97M SEK with 4.94% growth. CellaVision AB had revenue of 197.21M in the quarter ending December 31, 2025, with 5.63% growth.
Revenue
758.97M
Revenue Growth
+4.94%
P/S Ratio
4.73
Revenue / Employee
3.29M
Employees
231
Market Cap
3.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 758.97M | 35.75M | 4.94% |
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | 461.77M | 96.96M | 26.58% |
| Dec 31, 2018 | 364.81M | 55.50M | 17.94% |
| Dec 31, 2017 | 309.31M | 44.27M | 16.70% |
| Dec 31, 2016 | 265.04M | 25.65M | 10.71% |
| Dec 31, 2015 | 239.39M | 22.47M | 10.36% |
| Dec 31, 2014 | 216.92M | 37.07M | 20.61% |
| Dec 31, 2013 | 179.85M | 10.34M | 6.10% |
| Dec 31, 2012 | 169.51M | 14.11M | 9.08% |
| Dec 31, 2011 | 155.40M | 23.76M | 18.05% |
| Dec 31, 2010 | 131.64M | 22.66M | 20.80% |
| Dec 31, 2009 | 108.97M | 8.53M | 8.49% |
| Dec 31, 2008 | 100.44M | 25.88M | 34.71% |
| Dec 31, 2007 | 74.57M | 19.79M | 36.12% |
| Dec 31, 2006 | 54.78M | 15.76M | 40.39% |
| Dec 31, 2005 | 39.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elekta AB | 17.11B |
| Nolato AB | 9.46B |
| Vitrolife AB | 3.44B |
| MedCap AB | 2.11B |
| BICO Group AB | 1.50B |
| Xvivo Perfusion AB | 812.17M |
| C-Rad AB | 441.90M |
| Paxman AB | 323.56M |
CellaVision AB News
- 5 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus